Empowering Patients to Lead Fully Mobile Lives
High risk and chronically ill patients in Europe may soon find themselves able to lead independent and fully mobile lives thanks to the work of a project that has developed a Body Area Network of wireless sensors to remotely monitor vital signs.
(PRWEB) March 4, 2005
Since this IST-funded project MobiHealth ended in February 2004, the project partners have gone on to further develop the mobile healthcare system and expect to have a commercial product on the market by early next year, potentially marking a major advancement in European healthcare with benefits for both patients and doctors.
Patient empowerment
“Patient empowerment is all about ensuring patients can be independent and can go about their daily lives in comfort, it’s about not letting a disease constrain your life, about being able to go to work safe in the knowledge that if there are complications a healthcare professional is watching over you,” explains MobiHealth coordinator Rainer Herzog at Ericsson Enterprise in Germany.
That empowerment of patients was brought a step closer to becoming reality by the MobiHealth project with the creation of a comprehensive monitoring system that is among the most advanced developed to date.
“It’s highly advanced in the sense that it provides continuous, automatic data collection and transmission in real-time,” Herzog says. “Other systems generally store the data and then have to synchronise it locally with the databases of healthcare workers.”
At the heart of the MobiHealth system is what the project partners have termed a Body Area Network (BAN) comprised of wearable, non-intrusive sensors to monitor vital signs – everything from heart and breathing rates to oxygen saturation and muscular activity.
“The network is very adaptable in that different sensors can be added to monitor different body functions depending on the patient’s illness,” the coordinator notes.
The sensors are connected via Bluetooth wireless technology to a Mobile Base Unit, in essence a programmable mobile phone or PDA, that then transmits the data over GPRS or UMTS to the patientÂ’s doctor or healthcare centre.
MobiHealth on trial
Evaluation testing in 2003 showed the stability and effectiveness of the MobiHealth system as well as the feasibility of it being used in a wide range of medical fields. In trials in The Netherlands, for example, the system was used with trauma patients and pregnant women; in Sweden it was used to keep track of respiration and physical activity; in Germany to monitor cardiac patients; and in Spain it was tested in rehabilitation and homecare scenarios.
“The trials validated the feasibility of the system, not only from a technological and medical viewpoint but also in terms of acceptability,” Herzog says. “Almost everyone involved – patients and doctors – agreed that the system offered significant advantages. Patients particularly liked being monitored, with many saying that it gave them peace of mind and encouraged them to do more activities, while doctors saw that they could improve quality of care while reducing the workload.”
In an extension of the project’s original goals, the partners have also set about creating a “powerful analytical tool” to process the raw data received from the system and present it to healthcare workers in an “easy to use” format.
From the point of view of healthcare providers mobile health techniques will prove essential in the future if EuropeÂ’s overburdened national public health systems are to reduce costs while maintaining standards. By providing patientsÂ’ with remote monitoring services they do not necessarily need to take up a hospital bed or visit their doctor everyday, but will still receive the same or an even better quality of care.
That is the central premise behind the market areas being studied by the project partners for a commercial application of their system.
Towards commercialisation
“We are currently targeting the system toward four market areas that would be able to make the most out of MobiHealth initially,” Herzog notes. “People with chronic diseases, such as heart disease and asthma; people at risk, such as women with high-risk pregnancies; patients who have been hospitalised for surgery and who can be kept under observation remotely rather than keeping them in for in a hospital bed; and the pharmaceutical industry, where the system could be used to reduce the time and cost of clinical trials for drugs.”
The project coordinator also points to the potential for MobiHealth to be employed to monitor the elderly and disabled, given that the BAN can include a panic alarm and a “drop alarm” which will alert healthcare workers if a patient falls down and remains immobile.
“We’ve also included a localisation system based on triangulation between mobile relay antennas to allow emergency services to locate a patient in need,” Herzog notes.
The project partners are due to perform further evaluations of MobiHealth this year in order to gain authorisation for the technology from European health authorities with the aim of having a commercial system available in the first half of 2006.
Please mention IST Results as the source of this story and, if publishing online, please hyperlink to: http://istresults. cordis. lu/ (http://istresults. cordis. lu/)
Contact: Tara Morris, +32-2-2861985, tmorris@gopa-cartermill. com
###
